IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,663,260 | +12.2% | 36,668 | +1.5% | 0.01% | +16.7% |
| Q2 2023 | $1,482,742 | +12.0% | 36,138 | -2.4% | 0.01% | 0.0% |
| Q1 2023 | $1,323,917 | -2.8% | 37,043 | +2.8% | 0.01% | -7.7% |
| Q4 2022 | $1,361,495 | -11.2% | 36,047 | +3.9% | 0.01% | -18.8% |
| Q3 2022 | $1,534,000 | +20.3% | 34,680 | +0.7% | 0.02% | +33.3% |
| Q2 2022 | $1,275,000 | +0.2% | 34,441 | +0.3% | 0.01% | +20.0% |
| Q1 2022 | $1,272,000 | +22.3% | 34,354 | +0.5% | 0.01% | +25.0% |
| Q4 2021 | $1,040,000 | -10.3% | 34,190 | -1.1% | 0.01% | -11.1% |
| Q3 2021 | $1,159,000 | -15.7% | 34,557 | +0.3% | 0.01% | -18.2% |
| Q2 2021 | $1,375,000 | -20.2% | 34,461 | -10.0% | 0.01% | -26.7% |
| Q1 2021 | $1,722,000 | -20.0% | 38,299 | +0.6% | 0.02% | -25.0% |
| Q4 2020 | $2,152,000 | +12.6% | 38,055 | -5.5% | 0.02% | +5.3% |
| Q3 2020 | $1,911,000 | +4.1% | 40,274 | +29.4% | 0.02% | -26.9% |
| Q2 2020 | $1,835,000 | +26.2% | 31,127 | +1.2% | 0.03% | +4.0% |
| Q1 2020 | $1,454,000 | – | 30,752 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,529,838 | $404,393,000 | 11.39% |
| DOWLING & YAHNKE LLC | 676,379 | $41,888,000 | 5.27% |
| Opus Point Partners Management, LLC | 102,459 | $6,345,000 | 4.19% |
| WILLIAM HARRIS INVESTORS INC | 230,443 | $14,271,000 | 3.43% |
| PINNACLE ASSOCIATES LTD | 1,690,263 | $104,678,000 | 2.20% |
| MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ | 21,298 | $1,319,000 | 2.11% |
| Sonora Investment Management, LLC | 126,763 | $7,850,000 | 2.04% |
| Virtus ETF Advisers LLC | 10,447 | $647,000 | 1.78% |
| Apex Capital Management | 1,020,096 | $63,175,000 | 1.41% |
| PERKINS CAPITAL MANAGEMENT INC | 19,900 | $1,232,000 | 1.32% |